Inventor · disambiguated record
Marcus A. Horwitz
Also filed as: HORWITZ MARCUS · HORWITZ MARCUS A · HORWITZ MARCUS AARON
26 granted patents·11 pending applications·216 citations·filing 1988–2023
95Inventor score
Top patents by PatentIndex Score
37 records- 0191US5108745ATuberculosis and legionellosis vaccines and methods for their productionUNIV CALIFORNIA·Filed 1988·Granted Apr 28, 1992·67 cites·17 claims
- 0290US8206700B2Methods and compositions for treating tularemiaHORWITZ MARCUS A·Filed 2007·Granted Jun 26, 2012·16 cites·12 claims
- 0388US11045555B2Pathogen-specific cargo delivery and diagnostic platform based on mesoporous silica nanoparticlesUNIV CALIFORNIA·Filed 2019·Granted Jun 29, 2021·5 cites·18 claims
- 0485US10010595B2Live recombinant booster vaccine against tuberculosisUNIV CALIFORNIA·Filed 2014·Granted Jul 3, 2018·4 cites·20 claims
- 0582US6471967B1Recombinant intracellular pathogen vaccines and methods for useUNIV CALIFORNIA·Filed 2000·Granted Oct 29, 2002·14 cites·6 claims
- 0681US8124068B2Recombinant intracellular pathogen immunogenic compositions and methods of useHORWITZ MARCUS A·Filed 2009·Granted Feb 28, 2012·5 cites·9 claims
- 0780US6924118B2Recombinant intracellular pathogen immunogenic compositions and methods for useUNIV CALIFORNIA·Filed 2003·Granted Aug 2, 2005·12 cites·34 claims
- 0879US8287879B2Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of useHORWITZ MARCUS A·Filed 2007·Granted Oct 16, 2012·1 cites·27 claims
- 0977US7622107B2Recombinant intracellular pathogen immunogenic compositions and methods for useUNIV CALIFORNIA·Filed 2004·Granted Nov 24, 2009·6 cites·11 claims
- 1074US8383132B2Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of useUNIV CALIFORNIA·Filed 2011·Granted Feb 26, 2013·1 cites·20 claims
- 1172US8481024B2Vaccines against tularemiaHORWITZ MARCUS A·Filed 2010·Granted Jul 9, 2013·3 cites·12 claims
- 1272US8163294B2Growth regulatable recombinant BCG compositionsHORWITZ MARCUS A·Filed 2007·Granted Apr 24, 2012·2 cites·17 claims
- 1370US11224647B2Safe potent single platform vaccine against Tier 1 select agents and other pathogensUNIV CALIFORNIA·Filed 2017·Granted Jan 18, 2022·1 cites·14 claims
- 1470US6818223B2Abundant extracellular products and methods for their production and useUNIV CALIFORNIA·Filed 2001·Granted Nov 16, 2004·2 cites·24 claims
- 1568US5721209AIron chelator and inhibitor of iron-mediated oxidant injuryUNIV CALIFORNIA·Filed 1995·Granted Feb 24, 1998·30 cites·13 claims
- 1663US7300660B2Abundant extracellular products and methods for their production and useUNIV CALIFORNIA·Filed 2003·Granted Nov 27, 2007·1 cites·28 claims
- 1761US2025152690A1Novel live multi-antigenic recombinant vaccine against tuberculosisUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1860US2006142251A1Anti-microbial agents derived from methionine sulfoximine analoguesHARTH GUNTHER·Filed 2003·Application pending·0 cites
- 1959US8932846B2Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteinsHORWITZ MARCUS A·Filed 2008·Granted Jan 13, 2015·0 cites·6 claims
- 2059US2004157802A1Anti-microbial agents derived from methionine sulfoximine analoguesFiled 2003·Application pending·0 cites
- 2157US6054133AAnti-microbial targeting for intracellular pathogensUNIV CALIFORNIA·Filed 1997·Granted Apr 25, 2000·18 cites·15 claims
- 2254US2023181720A1Safe potent single vector platform vaccine against covid-19UNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 2353US10576079B2Multi-drug therapies for tuberculosis treatmentUNIV CALIFORNIA·Filed 2018·Granted Mar 3, 2020·0 cites·18 claims
- 2453US7002002B2Abundant extracellular products and methods for their production and useUNIV CALIFORNIA·Filed 2001·Granted Feb 21, 2006·0 cites·5 claims
- 2552US6599510B1Abundant extracellular products and methods for their production and useUNIV CALIFORNIA·Filed 1998·Granted Jul 29, 2003·13 cites·6 claims
- 2652US2013101614A1Novel live recombinant booster vaccine against tuberculosisHORWITZ MARCUS A·Filed 2011·Application pending·0 cites
- 2749US2003152584A1Abundant extracellular products and methods for their production and useFiled 2002·Application pending·0 cites
- 2845US6013660AExternally targeted prophylactic and chemotherapeutic method and agentsUNIV CALIFORNIA·Filed 1996·Granted Jan 11, 2000·5 cites·2 claims
- 2945US2006183676A1Treatment of mycobacterium tuberculosis with antisense oligonucleotidesHORWITZ MARCUS A·Filed 2002·Application pending·0 cites
- 3045US2004033972A1Treatment of mycobacterium tuberculosis with antisense polynucleotidesFiled 2000·Application pending·0 cites
- 3143US10080749B2Multi-drug therapies for tuberculosis treatmentUNIV CALIFORNIA·Filed 2015·Granted Sep 25, 2018·0 cites·17 claims
- 3243US2006182754A1Abundant extracellular products and methods for their production and useHORWITZ MARCUS A·Filed 2006·Application pending·0 cites
- 3342US5994346AUse of exochelins in the preservation of organs for transplantUNIV CALIFORNIA·Filed 1997·Granted Nov 30, 1999·3 cites·10 claims
- 3441US6761894B1Abundant extracellular products and methods for their production and useUNIV CALIFORNIA·Filed 1995·Granted Jul 13, 2004·4 cites·7 claims
- 3539US2003124135A1Recombinant intracellular pathogen vaccines and methods for useHORWITZ MARCUS A·Filed 2002·Application pending·0 cites
- 3634US6752993B1Abundant extracellular product vaccines and methods for their production and useUNIV CALIFORNIA·Filed 1993·Granted Jun 22, 2004·3 cites·24 claims
- 3733US2002150592A1Abundant extracellular products and methods for their production and useUNIV CALIFORNIA·Filed 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →